Single-institution experience using transarterial chemoembolization (TACE) with carboplatinum (carbo) and doxorubicin in patients (pts) with hepatocellular carcimona (HCC) awaiting liver transplantation (LTx).

Authors

Bradley Switzer

University of Massachusetts Medical Center

Bradley Switzer , Bilal Piperdi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC): Background.

First Author: Tim Meyer

insert_chart_outlined

Poster

2020 ASCO Virtual Scientific Program

bookmark_border

Algorithm for blood-based panel of methylated DNA and protein markers to detect early-stage hepatocellular carcinoma with high specificity.

First Author: Naga P. Chalasani

insert_chart_outlined

Poster

2020 Gastrointestinal Cancers Symposium

bookmark_border

Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2.

First Author: Peter R. Galle

insert_chart_outlined

Poster

2019 Gastrointestinal Cancers Symposium

bookmark_border

MAPK pathway proteins expression and correlation with clinicopathological indices and long-term outcome according to the etiology of underlying chronic liver disease in hepatocellular carcinoma.

First Author: Paulo Henrique Costa Diniz